(19)
(11) EP 3 638 694 A1

(12)

(43) Date of publication:
22.04.2020 Bulletin 2020/17

(21) Application number: 17743107.9

(22) Date of filing: 16.06.2017
(51) International Patent Classification (IPC): 
C07K 16/18(2006.01)
A61P 25/28(2006.01)
A61K 39/395(2006.01)
(86) International application number:
PCT/US2017/037991
(87) International publication number:
WO 2018/231254 (20.12.2018 Gazette 2018/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(71) Applicant: Bristol-Myers Squibb Company
Princeton, NJ 08543 (US)

(72) Inventors:
  • TIRUCHERAI, Giridhar
    Kendall Park, New Jersey 08824 (US)
  • BURGESS, Michael Frans
    Chester, NJ 07930 (US)
  • HUANG, Masano Tlaneci
    Cranbury, NJ 08512 (US)
  • BURTON, Lori S.
    Robbinsville, NJ 08691 (US)
  • QUAN, Yong
    Dublin, CA 94568 (US)

(74) Representative: Pohlman, Sandra M. 
df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16
80333 München
80333 München (DE)

   


(54) COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES